Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges

In the absence of effective endogenous repair mechanisms after cardiac injury, cell-based therapies have rapidly emerged as a potential novel therapeutic approach in ischaemic heart disease. After the initial characterization of putative endothelial progenitor cells and their potential to promote ca...

Full description